Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-002912
Filing Date
2013-05-15
Accepted
2013-05-15 17:20:38
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT hmbk_10q.htm 10-Q 939642
2 CERTIFICATION hmbk_ex311.htm EX-31.1 15628
3 CERTIFICATION hmbk_ex312.htm EX-31.2 16720
4 CERTIFICATION hmbk_ex321.htm EX-32.1 9183
  Complete submission text file 0001354488-13-002912.txt   4187310

Data Files

Seq Description Document Type Size
5 hbmk-20130331.xml EX-101.INS 516169
6 hbmk-20130331.xsd EX-101.SCH 43030
7 hbmk-20130331_cal.xml EX-101.CAL 52905
8 hbmk-20130331_def.xml EX-101.DEF 74025
9 hbmk-20130331_lab.xml EX-101.LAB 246183
10 hbmk-20130331_pre.xml EX-101.PRE 171443
Mailing Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864
Business Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864 65-6747-7883
Hubei Minkang Pharmaceutical Ltd. (Filer) CIK: 0001375850 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53231 | Film No.: 13848586
SIC: 2834 Pharmaceutical Preparations